Searched for
PHARMACEUTICAL COMPANIES
Trump’s vaccine overhaul could bring more shots, higher costs for US familiesPresident Donald Trump's vaccine plan faces significant financial and logistical hurdles. Drugmakers must develop new manufacturing process...- 'You are using sword to kill mosquito': Bombay HC tells Tukaram Mundhe-led FDA to use power judiciouslyThe Bombay High Court has told the Tukaram Mundhe-led Maharashtra FDA to use its powers judiciously after Cadila Pharmaceuticals challenged...
- Govt tightens drug quality net, initiates 950 actions since 2022: Over 1,100 cough syrup makers facing intensive audits amid quality concernsThe government has initiated 950 enforcement actions against pharmaceutical companies since December 2022. These actions aim to improve the...
- Independence Day 2026: The Kolkata chemist who sold foreign medicines, backed Swadeshi and built a pharma empireIndependence Day 2026: Butto Kristo Paul & Co. started as a modest establishment focused on importing foreign medicines. Over time, it blos...
- India sets sail to add more trade muscle as it signs PTA terms with SACUIndia and the Southern African Customs Union signed terms to start trade negotiations. This move revives talks after previous rounds stalle...
- Marksans Pharma shares rally over 9% after Q1 profit spikes 174% YoY to Rs 159 croreMarksans Pharma shares surged after Q1FY27 profit jumped 174% YoY to Rs 159 crore. Revenue rose 35.6% to Rs 841 crore, while EBITDA hit a r...
- Sun will require HC nod for Semaglutide tablet launchThe Delhi High Court has directed Sun Pharma Laboratories to seek its approval before launching semaglutide tablets, following Novo Nordisk...
- Bombay HC warns Maharashtra FDA for ‘sword to kill mosquito’ approach as Cadila challenges drug banThe Bombay High Court criticized the Maharashtra FDA for its drastic actions against companies. The court directed the regulator to grant h...
- UK first in Europe to approve Eli Lilly oral weight loss drugBritain has become the first country in Europe to approve orforglipron, the oral weight loss and diabetes treatment developed by US company...
- Zydus Lifesciences Q1 Results: Net profit down 36% at Rs 939.8 croreZydus Lifesciences reported a significant year-on-year decline of thirty-six percent in net profit for the first quarter, despite a robust ...
- India, South Africa-led SACU group may ink terms of reference for negotiating trade pact on Aug 12India and the SACU group will sign terms of reference for trade talks. Negotiations for a preferential trade agreement are expected to begi...
- Independence Day 2026: India, which once couldn't make smallpox vaccine, has now crossed a pharma milestone the world can't ignore2026 Independence Day: India's pharmaceutical industry marks a historic milestone with a new drug approval. This achievement reflects decad...
- Akums Drugs shares rally 9% hit 52-week high after Q1 results; stock up 67% YTDAkums Drugs shares rose sharply on Monday to hit a 52-week high after the company reported strong Q1 FY27 results. Revenue rose 13.9% year-...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- Gland Pharma inks strategic CDMO deal with global pharma firm, eyes $90-100 million annual revenueGland Pharma has signed a strategic Manufacturing and Supply Agreement with a leading global pharmaceutical company for technology transfer...
- Forget Nvidia chips, China's next big race is being slowed down by an unlikely rival: monkeysLab primate prices in China have surged over 1,000% in eight years, with a single cynomolgus macaque now costing around Rs 22 lakh. The sho...
- Emcure Pharma net profit up 36% at Rs 292 croreEmcure Pharmaceuticals reported a 23% revenue increase in the first quarter. Ebitda grew 25.8% with improved margins, reflecting productivi...
- IPA seeks to regularise 'legacy' drugsThe Indian Pharmaceutical Alliance seeks to regularize many drugs. These drugs have been marketed for years without central approval. Examp...
- As we look to the next decade, I hope in the future we can further grow in generics as we transition into drug innovation: Aman Mehta, MD, Torrent PharmaceuticalsTorrent Pharma aims to become a top three Indian drug maker. The company is transitioning from generics to drug innovation for growth. Aman...
Load More
